scispace - formally typeset
M

Michel Vidaud

Researcher at Paris Descartes University

Publications -  101
Citations -  5633

Michel Vidaud is an academic researcher from Paris Descartes University. The author has contributed to research in topics: Gene & Neurofibromatosis. The author has an hindex of 36, co-authored 101 publications receiving 5136 citations. Previous affiliations of Michel Vidaud include Institut Gustave Roussy & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Characterization of a Germ-Line Deletion, Including the Entire INK4/ARF Locus, in a Melanoma-Neural System Tumor Family: Identification of ANRIL, an Antisense Noncoding RNA Whose Expression Coclusters with ARF

TL;DR: A new large antisense noncoding RNA (named ANRIL) is identified within the 403-kb germ-line deletion of the p15/CDKN2B-p16/CD KN2A-p14/ARF locus putatively involved in melanoma-NST syndrome families and in melanomas-prone families with no identified p16/ CDKN2A mutations as well as in somatic tumors.
Journal ArticleDOI

Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid.

TL;DR: An approach based on a polymerase-chain-reaction (PCR) test performed on amniotic fluid is rapid, safe, and accurate for the prenatal diagnosis of congenital T. gondii infection.
Journal ArticleDOI

PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies

TL;DR: Genomic, cellular, and mouse modelling data are provided demonstrating that the polycomb group gene SUZ12 functions as tumour suppressor in PNS tumours, high-grade gliomas and melanomas by cooperating with mutations in NF1 and it is shown that SUZ 12 loss potentiates the effects of NF1 mutations by amplifying Ras-driven transcription through effects on chromatin.
Journal ArticleDOI

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity.

TL;DR: H hepatitis C virus patients with normal ALT showed weaker histological activity and lower fibrosis scores, and the progression rate of fibrosis was twice as slow as in HCV patients with elevated ALT, which was associated with high alcohol consumption.